EZH2, a key catalytic subunit of PRC2, functions as a histone methyltransferase that specifically induces histone H3 lysine 27 trimethylation (H3K27me3) to target genes [35]; EZH2 overexpression plays an important role in cancer development and progression [36, 37]. Here, PRDM9 is linked to cancer.